SHAREHOLDER ALERT: WeissLaw LLP Investigates Obalon Therapeutics, Inc.

NEW YORK, Jan. 21, 2021 /PRNewswire/ — WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ: OBLN) in connection with the proposed merger of the Company…